Joshua Johnstone

Joshua Johnstone has worked in various roles in the pharmaceutical industry since 2011. Starting as a Post Doctoral Fellow at the Veterans Affairs Medical Center, they then moved to Insero Health, Inc. as the Associate Director of Research and Development. In 2015, they became the Director of Research and Development - Neurology at Biscayne Pharmaceuticals, Inc. and in 2016, they were promoted to Director of Research and Development at Biscayne Neurotherapeutics. From 2018 to 2020, they were a Pharmaceutical Contractor for himself. In 2019, they joined Supernus Pharmaceuticals, Inc. as a Senior Clinical Program Manager and in 2021, they were appointed as the Senior Director of Research and Development at Xalud Therapeutics, Inc.

Joshua Johnstone attended Washington State University from 1999 to 2004, where they earned a Bachelor of Science (B.S.) in Neuroscience and a Bachelor of Science (B.S.) in Psychology. Joshua then attended the University of Miami Miller School of Medicine from 2005 to 2011, where they earned a Doctor of Philosophy (Ph.D.) in Neuroscience.